Arkolith/Insider Trading/RGNX/Form 4

Simpson Curran

Chief Executive Officer, DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Oct 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Sell(S)21K$12.62$263K216K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001346164-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML